Implanting the
Reveal LINQ™ ICM

In-office insertions are faster and easier than you may think.

Easy to insert

Insertion of a Reveal LINQ insertable cardiac monitor (ICM) typically takes less than five minutes. It entails making a small < 1 cm incision with a preloaded insertion tool that 97% of physicians found to be intuitive.1

Clinical evidence

The RIO2 study demonstrates the safety and feasibility of implanting the Reveal LINQ ICM outside of the cath lab.2

  • Safe: In-office and hospital insertions have the same low complication rate of < 1%.1
  • Efficient: 36% reduction in procedure time for insertions performed in-office versus in the hospital.2
  • High patient satisfaction: 85% of in-office patients had a very positive insertion experience; 33% higher satisfaction for in-office patients versus hospital patients.2
Patient Pam Watertown holding her CareLink cardiac monitor system across her chest at her bedside

Patient connectivity

Plug-and-play bedside monitor

  • Remotely transmit cardiac data using the CareLink™ network.
  • No magnets required.
  • No secondary mobile devices required.
  • No need for in-person interrogation.

Reveal LINQ remotely and securely transmits cardiac data to the clinic via the CareLink monitor.

Data flowing from Reveal LINQ ICM to MyCareLink patient monitor to the computer screen

Patient selection

Learn more about patient eligibility for the LINQ family of ICMs.

Explore the portfolio

When you need answers, trust the most accurate ICMs on the market.3-15

LINQ II and Reveal LINQ insertable cardiac monitors shown horizontally

Learn more about challenging conditions

Get more details about the conditions that may require long-term cardiac monitoring with the LINQ family of ICMs.


™Third-party brands are trademarks of their respective owners.



Pürerfellner H, Sanders P, Pokushalov E, et al. Miniaturized Reveal LINQ insertable cardiac monitoring system: First-in-human experience. Heart Rhythm. June 2015;12(6):1113-1119.


Rogers JD, Sanders P, Piorkowski C, et al. In-office insertion of a miniaturized insertable cardiac monitor: Results from the Reveal LINQ In-Office 2 randomized study. Heart Rhythm. February 2017;14(2):218-224.


Pürerfellner H, Sanders P, Sarkar S, et al. Adapting detection sensitivity based on evidence of irregular sinus arrhythmia to improve atrial fibrillation detection in insertable cardiac monitors. Europace. November 1, 2018;20(FI_3):f321-f328.


Nölker G, Mayer J, Boldt L, et al. Performance of an Implantable Cardiac Monitor to Detect Atrial Fibrillation: Results of the DETECT AF Study. J Cardiovasc Electrophysiol. December 2016;27(12):1403-1410.


Confirm Rx™* ICM K163407 FDA clearance letter. 2017.


Confirm Rx ICM K182981 FDA clearance letter. 2019.


Jot Dx™* ICM K212206 FDA clearance letter. 2021.


Monitoring Devices Merlin PCS Help Manual for SJM Confirm™*, Confirm Rx ICM, Jot Dx Manual. 2021


BIOTRONIK BioMonitor™* 2 technical manual. 2017.


BIOTRONIK BIOMONITOR III technical manual. 2020.


BIOTRONIK BIOMONITOR IIIm technical manual. 2020


BIOTRONIK BIOMONITOR III. K190548 FDA clearance. 2019.


BIOTRONIK BIOMONITOR IIIm. K201865 FDA clearance. 2020.


Lux-Dx™* ICM K212206 FDA clearance letter. 2020.


Lux-Dx ICM user manual. 2020.